Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

NCT02850263 ·Status: COMPLETED

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

NCT01783886 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

NCT06929143 ·Status: ACTIVE_NOT_RECRUITING

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

NCT06879301 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

NCT03453281 ·Status: COMPLETED ·Phase: PHASE4

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

NCT05511038 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

NCT02559180 ·Status: COMPLETED ·Phase: PHASE4

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

NCT04429503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

NCT04288232 ·Status: COMPLETED ·Phase: PHASE3

Diabetic Retinopathy Assessed by Ultra-wide

NCT03157206 ·Status: UNKNOWN

The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy

NCT03006081 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

NCT02581995 ·Status: COMPLETED ·Phase: PHASE4

3 Month Outcome of Ziv-aflibercept for DME

NCT02772497 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept

NCT03056079 ·Status: UNKNOWN ·Phase: PHASE4

DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact

NCT00789477 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Refractory Diabetic Macular Edema With Infliximab

NCT00505947 ·Status: TERMINATED ·Phase: PHASE3

Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection

NCT03297684 ·Status: UNKNOWN

Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema

NCT02949024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece

NCT05683912 ·Status: COMPLETED

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema

NCT02441907 ·Status: COMPLETED ·Phase: PHASE4

Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)

NCT03780361 ·Status: COMPLETED ·Phase: PHASE4

A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema

NCT06422507 ·Status: COMPLETED ·Phase: PHASE3

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)

NCT02788877 ·Status: UNKNOWN ·Phase: PHASE4

Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa

NCT02554747 ·Status: COMPLETED ·Phase: NA

The Results of Pars Plana Vitrectomy in Diabetic Macular Edema

NCT03384901 ·Status: UNKNOWN